Potential Benefits of Iopofosine I 131 in Waldenström Macroglobulinemia

A new radiotherapeutic agent, iopofosine I 131, is showing promising potential for patients with Waldenström macroglobulinemia, according to Francisco Hernandez-Ilizaliturri, MD, of Roswell Park Comprehensive Cancer Center. The initial phase 2 CLOVER-1 trial demonstrated notable efficacy and safety signals for heavily pretreated patients with this condition, leading to the initiation of the CLOVER-WaM expansion cohort specifically for Waldenström macroglobulinemia.

Preliminary data from the expansion cohort indicated durable responses and a manageable safety profile for iopofosine I 131, with ongoing observations suggesting that responses may continue to improve months after treatment completion. This unique feature could give iopofosine I 131 an advantage over current therapies, Hernandez-Ilizaliturri noted.

One of the key features of iopofosine I 131 is its novel mechanism of action and finite treatment duration compared to continuous therapies like BTK inhibitors. Despite providing deep responses, iopofosine I 131 allows for treatment completion, which may be preferable for some patients.

Safety data from 44 patients with Waldenström macroglobulinemia receiving iopofosine I 131 showed primarily grade 1/2 hematologic toxicities, with reversible instances of grade 3 or higher anemia or neutropenia. Importantly, no vascular or renal adverse effects were reported with iopofosine I 131, setting it apart from other available agents for this condition.

Overall, the preliminary efficacy and safety findings suggest that iopofosine I 131 could be a favorable therapeutic option for patients with Waldenström macroglobulinemia. This new radiotherapeutic agent offers hope for improved outcomes in this patient population.


More from this stream


‘Infrastructure division bolstered by Geobear’

Ground engineering and subsidence specialist Geobear has recruited Arcadis technical director Paul Garthwaite. Paul Garthwaite Paul Garthwaite...

The Future of Business with e-Signature Adoption

In the fast-paced world of modern business, adopting digital tools and solutions is not just an option but a necessity for staying efficient. Among the numerous advancements, e-signature solutions have emerged as a cornerstone technology that enables companies to streamline their operations, lower costs, and improve security. This technology facilitates signing documents electronically, eliminating the […]

The post Future of Business with e-Signature Adoption appeared first on Insights Success.

‘Leading Chinese Online Portal Emerges Victorious in Fierce Competition’

Sohu.com, one of the most prominent online portals in China, continues to solidify its position in the digital landscape. With a diverse range of services and a user-friendly interface, the website...

‘Platform Revolutionizing Online Publishing’

Medium.com, the popular online publishing platform, has gained immense popularity among writers, journalists, and readers alike. With a mission to elevate the quality of online content and build a...

Key to Searching for Alien Life Could Lie in Purple Planets, Not Green Ones

Science fiction films have shaped our collective imagination into believing that any planet harboring extra-terrestrial life would look like a lush green utopia, somewhat like Earth....